Company
Elephas Biosciences
| Industry | private company that has developed a live tumor profiling platform for immunotherapy response prediction |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Elephas Biosciences | Series B-2 | 2025-11-06 |
| Elephas Biosciences | Series C | 2024-01-23 |